MILLENNIUM MANAGEMENT LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,441,581
-82.7%
118,351
-75.3%
0.00%
-85.7%
Q2 2023$14,111,269
+158453.6%
478,186
+23.8%
0.01%
+40.0%
Q1 2023$8,900
+7.7%
386,289
+30.0%
0.01%0.0%
Q4 2022$8,262
-99.9%
297,093
-40.1%
0.01%
-44.4%
Q3 2022$15,228,000
-19.8%
496,184
-23.1%
0.01%
-25.0%
Q2 2022$18,992,000
+2218.9%
645,336
+3414.9%
0.01%
Q4 2021$819,000
-61.2%
18,360
-56.1%
0.00%
-100.0%
Q3 2021$2,111,000
-62.5%
41,842
-41.7%
0.00%
-75.0%
Q2 2021$5,627,000
+23.6%
71,743
-10.0%
0.00%0.0%
Q1 2021$4,552,000
-2.6%
79,712
+42.8%
0.00%
+33.3%
Q4 2020$4,675,000
+2.2%
55,814
-56.3%
0.00%
-50.0%
Q3 2020$4,575,000
+748.8%
127,688
+472.4%
0.01%
+500.0%
Q2 2020$539,000
-65.4%
22,309
-78.1%
0.00%
-50.0%
Q3 2019$1,557,000
+94.6%
101,659
+195.1%
0.00%
+100.0%
Q1 2019$800,000
-69.5%
34,451
-80.0%
0.00%
-66.7%
Q2 2018$2,623,000
+77.8%
171,979
+82.3%
0.00%
+50.0%
Q4 2017$1,475,00094,3160.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders